Want to see MED full AI Analyst Report?
MED Stock Chart & Stats
$9.68
$0.23(2.38%)
At close: 4:00 PM EDT
$9.68
$0.23(2.38%)
Day’s Range― - ―
52-Week Range$9.22 - $15.11
Previous Close$9.91
Volume152.25K
Average Volume (3M)183.09K
Market Cap
$109.30M
Enterprise Value-$24.06
Total Cash (Recent Filing)$71.91M
Total Debt (Recent Filing)$27.62M
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Nov 09, 2026EPS Estimate
-0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.33
Shares Outstanding11,119,115
10 Day Avg. Volume175,854
30 Day Avg. Volume183,095
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.59
Price to Sales (P/S)0.30
P/FCF Ratio93.90
Enterprise Value/Market Cap>-0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$12.00Price Target Upside23.97% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-1.85
Revenue Forecast (FY)$279.70M
Bulls Say, Bears Say
Bulls Say
High Gross MarginSustained gross margins around 69–74% indicate attractive unit economics for packaged nutrition products. This margin buffer gives Medifast flexibility to absorb promotional spend or invest in product development and coach support while margins underpin long-term profitability once revenue stabilizes or fixed-costs are reduced.
Strong Liquidity & No DebtA cash-rich, low-leverage balance sheet provides a durable runway to execute the Trilivy rebrand, fund Catalyst restructuring, and support working capital targets without refinancing risk. This financial flexibility materially reduces bankruptcy and liquidity risks during the multi-quarter recovery.
Strategic Rebrand & Science InvestmentThe Trilivy rebrand plus creation of a Metabolic Health Institute represent a structural repositioning toward broader metabolic health, not just weight loss. That enhances differentiation, supports evidence-based claims, strengthens coach training, and could expand addressable market and clinical credibility over the medium term.
Bears Say
Material Revenue ContractionRevenue has declined steeply over multiple years, eroding scale and fixed-cost absorption. Even with strong gross margins, a much smaller revenue base makes returning to historic profitability harder and increases sensitivity to any further sales disruption or slower-than-expected coach recovery.
Sharp Coach AttritionThe coach network is the core distribution and retention engine; losing nearly half the active earning coaches is a structural impairment to customer acquisition and recurring purchases. Rebuilding coach count and productivity requires sustained incentives, training and product-market fit, which can take many quarters.
Operating Losses And Margin PressureMedifast has moved from prior operating profitability to losses driven by volume decline and fixed-cost deleverage. Negative operating margins constrain reinvestment and make the company reliant on successful cost programs and revenue recovery to reach sustainable profitability; execution risk is high.
Medifast News
MED FAQ
What was Medifast Inc’s price range in the past 12 months?
Medifast Inc lowest stock price was $9.22 and its highest was $15.11 in the past 12 months.
What is Medifast Inc’s market cap?
Medifast Inc’s market cap is $109.30M.
When is Medifast Inc’s upcoming earnings report date?
Medifast Inc’s upcoming earnings report date is Nov 09, 2026 which is in 95 days.
How were Medifast Inc’s earnings last quarter?
Medifast Inc released its earnings results on Aug 03, 2026. The company reported -$0.28 earnings per share for the quarter, beating the consensus estimate of -$0.65 by $0.37.
Is Medifast Inc overvalued?
According to Wall Street analysts Medifast Inc’s price is currently Undervalued.
Does Medifast Inc pay dividends?
Medifast Inc pays a Quarterly dividend of $1.65 which represents an annual dividend yield of N/A. See more information on Medifast Inc dividends here
What is Medifast Inc’s EPS estimate?
Medifast Inc’s EPS estimate is -0.35.
How many shares outstanding does Medifast Inc have?
Medifast Inc has 11,119,115 shares outstanding.
What happened to Medifast Inc’s price movement after its last earnings report?
Medifast Inc reported an EPS of -$0.28 in its last earnings report, beating expectations of -$0.65. Following the earnings report the stock price went up 34.292%.
Which hedge fund is a major shareholder of Medifast Inc?
Currently, no hedge funds are holding shares in MED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Medifast Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$12.00 (23.97% Upside)
$12.00 (23.97% Upside)
Blogger Sentiment
Bullish
MED Sentiment 75%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 294.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $63.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-25.03%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-3.32%
Trailing 12-Months
Company Description
Medifast Inc
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
MED Company Deck
MED Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: materially negative near-term operating and top-line trends (notably a 27.6% revenue decline and a 48.7% drop in active coaches) contrast with strong strategic initiatives, improving coach productivity (+41% YoY), a healthy balance sheet ($169.8M cash, no debt), and targeted cost actions (Catalyst) with a goal to return to profitability in Q4 2026. Management emphasized structural steps (new Trilivy brand, scientific institute, compensation changes and training) that could drive medium-term recovery, but sizable current financial pressures and near-term uncertainty remain.View all MED earnings summariesMED Stock 12 Month Forecast
Average Price Target
$12.00
▲(23.97% Upside)
Technical Analysis
Ownership Overview
5.36% Insiders
14.59% Mutual Funds
5.02% Other Institutional Investors
61.63% Public Companies and
Individual Investors